|
DE3612211A1
(de)
|
1986-04-11 |
1987-10-15 |
Basf Ag |
Kontinuierliches verfahren zum tablettieren
|
|
DE19710008A1
(de)
*
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
|
|
DK1067910T3
(da)
|
1998-04-03 |
2004-10-04 |
Egalet As |
Komposition med styret afgivelse
|
|
US7141250B2
(en)
|
2001-08-06 |
2006-11-28 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing bittering agent
|
|
US20040253310A1
(en)
|
2001-09-21 |
2004-12-16 |
Gina Fischer |
Morphine polymer release system
|
|
DE10252667A1
(de)
|
2002-11-11 |
2004-05-27 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
DE602004014747D1
(de)
|
2003-03-26 |
2008-08-14 |
Egalet As |
Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
PT1842533E
(pt)
*
|
2003-08-06 |
2013-05-17 |
Gruenenthal Gmbh |
Forma de dosagem protegida contra abuso
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE10360792A1
(de)
|
2003-12-23 |
2005-07-28 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
PL1740156T3
(pl)
|
2004-04-22 |
2011-12-30 |
Gruenenthal Gmbh |
Sposób wytwarzania zabezpieczonej przed nadużyciem, stałej postaci aplikacyjnej
|
|
CA2572491A1
(en)
|
2004-07-01 |
2006-01-12 |
Gruenenthal Gmbh |
Oral dosage form safeguarded against abuse
|
|
PL1765298T3
(pl)
|
2004-07-01 |
2013-01-31 |
Gruenenthal Gmbh |
Sposób wytwarzania stałej postaci dawkowania, która jest zabezpieczona przez nadużywaniem, wykorzystujący wytłaczarkę z przekładnią planetarną
|
|
AR053304A1
(es)
|
2004-07-01 |
2007-05-02 |
Gruenenthal Gmbh |
Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
|
|
JP4563787B2
(ja)
*
|
2004-12-10 |
2010-10-13 |
日立プラズマディスプレイ株式会社 |
プラズマディスプレイ装置及びその制御方法
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
NZ563846A
(en)
|
2005-06-03 |
2010-03-26 |
Egalet As |
A drug delivery system for delivering active substances dispersed in a dispersion medium
|
|
US20100172989A1
(en)
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
RU2433817C2
(ru)
*
|
2006-01-21 |
2011-11-20 |
Эбботт Гмбх Унд Ко.Кг |
Лекарственная форма и способ для доставки вызывающих зависимость лекарственных веществ
|
|
EP2104493A2
(en)
|
2007-01-16 |
2009-09-30 |
Egalet A/S |
Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
ES2963291T3
(es)
|
2007-04-26 |
2024-03-26 |
Sublimity Therapeutics Ltd |
Fabricación de múltiples minicápsulas
|
|
US8821928B2
(en)
|
2007-06-04 |
2014-09-02 |
Egalet Ltd. |
Controlled release pharmaceutical compositions for prolonged effect
|
|
TWI454288B
(zh)
*
|
2008-01-25 |
2014-10-01 |
Gruenenthal Chemie |
藥物劑型
|
|
AU2009320181B2
(en)
*
|
2008-10-27 |
2015-08-27 |
Alza Corporation |
Extended release oral acetaminophen/tramadol dosage form
|
|
NZ594071A
(en)
|
2009-01-26 |
2013-01-25 |
Egalet Ltd |
Controlled release formulations comprising morphine sulphate for continuous treatment of pain
|
|
ES2607209T3
(es)
|
2009-02-06 |
2017-03-29 |
Egalet Ltd. |
Composiciones farmacéuticas resistentes al abuso
|
|
AU2010265213B2
(en)
|
2009-06-24 |
2012-08-23 |
Egalet Ltd. |
Controlled release formulations
|
|
ES2534908T3
(es)
*
|
2009-07-22 |
2015-04-30 |
Grünenthal GmbH |
Forma de dosificación de liberación controlada extruida por fusión en caliente
|
|
LT2838512T
(lt)
*
|
2012-04-18 |
2018-11-12 |
GrĆ¼nenthal GmbH |
Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|